期刊文献+

配体结构对含2-甲基咪唑及N-乙基咪唑的NAMI衍生物水解及溶液稳定性的影响

Influence of Ligand Structure on the Hydrolysis and Stability of NAMI Derivatives Containing 2-Methyl imidazole and N-Ethyl imidazole
原文传递
导出
摘要 制备并用UV、循环伏安(CV)和NMR法研究了NAMI(新抗肿瘤转移抑制剂,trans-[RuCl4(DMSO)(imidazole)]Na·2DMSO)衍生物trans-[RuCl4(DMSO)(2-MeIm)]Na·2DMSO(2-MeIm=2-甲基咪唑,化合物1)和trans-[RuCl4(DMSO)-(N-EtIm)]Na·2DMSO(N-EtIm=N-乙基咪唑,化合物2)的水解机理-动力学、溶液稳定性和电化学性质.化合物1和化合物2与NAMI相似,在pH 7.40的缓冲溶液中发生两步脱氯水解反应(I氯水解及II氯水解)(分步反应);在酸性溶液(pH 5.00)中脱DMSO水解.通过线性拟合得到各水解反应速率常数kobs及半衰期t1/2.结果表明化合物在酸性溶液中的稳定性相对较高.在NAMI衍生物咪唑环的N位引入乙基比在2位引入甲基生成的化合物稳定.含氮配体相同时,NAMI-A(新抗肿瘤转移抑制剂,A:该系列中的第一个化合物,trans-[RuCl4(DMSO)(imidazole)][Himidazole])衍生物略比相应的NAMI衍生物稳定. Two NAMI (new antitumor metastasis inhibitor; trans-[RuC14(DMSO)(imidazole)]Nao2DMSO) derivatives, trans-[RuC14(DMSO)(2-MeIm)Na,2DMSO (2-MeIm=2-methyl imidazole, Compd. l) and trans-[RuC14(DMSO)(N-EtIm)]Na.2DMSO (N-EtIm=N-ethyl imidazole, Compd. 2) were prepared. Their hydrolytic mechanism-kinetics in pH 7.40/5.00 buffer solution and stability in physiological condition were investigated by UV, cyclic voltammetry (CV) and NMR. Similar to NAMI, both compounds undergo two well separated steps chloro-hydrolysis in pH 7.40 buffer solution; while dimethyl sulfoxide (DMSO) hydrolyze in pH 5.00 acetic buffer solution. The kobs and t1/2 for each reaction were determined. In conclusion, the stability of the complex in acidic solution is much more stable. The stability of the complex formed by introducing ethyl group at N position of imidazole ring would be much better than that of complex formed by introducing methyl group at 2 position of imidazole. The NAMI-A (new antitumuor metastasis inhibitor, A: this is the first of a series; trans-[RuCl4(DMSO)(imidazole)][Himidazole]) derivatives are somewhat morestable than the relative NAMI derivatives.
出处 《化学学报》 SCIE CAS CSCD 北大核心 2012年第7期864-872,共9页 Acta Chimica Sinica
基金 澳门科技发展基金(No.012/2009/A1) 中国中医科学院基本科研业务费自主选题(No.ZZ03064)资助项目~~
关键词 钌化合物 2-甲基咪唑 N-乙基咪唑 抗转移 水解动力学 稳定性 ruthenium complexes 2-methyl imidazole N-ethyl imidazole anti-metastasis hydrolytic ki-netics stabilities
  • 相关文献

参考文献4

二级参考文献175

  • 1Dyson P J, Sava G. J. Chem. Soc., Dalton Trans., 2006:1929 -1933
  • 2Bouma M, Nuijen B, Jansen M T, et al. Int. J. Pharrn., 2002, 248(1-2):239-246
  • 3Bergamo A, Gava B, Alessio E, et al. Int. J. Oncol., 2002,21 (6):1331-1338
  • 4Brindell M, Piotrowska D, Shoukry A A, et al. J. Biol. Inorg. Chem., 2007,12(6):809-818
  • 5Mestroni G, Allessio E, Sava G. United States Patent. Patent No.US 6,221,905 B1, 2001.
  • 6Mestroni G, Allesio E, Sava G, et al. United States Patent,Patent No.US 6,921,824 B1, 2005.
  • 7Bergamo A, Stocco G, Casarsa C, et al. Int. J. Oncol., 2004, 24:373-379
  • 8Bacac M, Hotze A C, van der Schilden K, et al. J. lnorg. Biochem., 2004,98(2):402-412
  • 9Messori L, Orioli P, Vullo D, et al. Eur. J. Biochem., 2000, 267(4): 1206- 1213
  • 10Frausin F, Scarcia V, Cocchietto M, et al. J. Pharmacol. Exp. Ther., 2005,313(1):227-233

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部